Sivahari Prasad Gorantla
Biologe
Geboren:
1980
Hat mitgewirkt an:
-
Studies on the functional domains in oncogenic JAK2 and identification of drug resistant mutations in FIP1L1-PDGFRA
-
Studies on the functional domains in oncogenic JAK2 and identification of drug resistant mutations in FIP1L1-PDGFRa
-
Type II mode of JAK2 inhibition and destabilization are potential therapeutic approaches against the ruxolitinib resistance driven myeloproliferative neoplasms
-
A newly identified 45‐kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance